IRIDEX (NASDAQ:IRIX) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of IRIDEX (NASDAQ:IRIX) in a report published on Friday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

IRIDEX Trading Down 1.0 %

Shares of IRIX opened at $1.51 on Friday. IRIDEX has a 1 year low of $1.27 and a 1 year high of $3.65. The company has a current ratio of 1.54, a quick ratio of 0.85 and a debt-to-equity ratio of 0.55. The stock has a 50 day simple moving average of $1.65 and a 200-day simple moving average of $1.72. The stock has a market cap of $25.04 million, a PE ratio of -2.25 and a beta of 0.84.

IRIDEX Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.